NLS Pharmaceutics AG (NLSP) — Financial Flexibility Index
NLS Pharmaceutics AG (NLSP) has a Financial Flexibility Index of -1.43x as of September 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $0.00) represents -1% of total liabilities ($1.46 Million). Check NLS Pharmaceutics AG (NLSP) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NLS Pharmaceutics AG Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NLS Pharmaceutics AG across 8 annual periods. For the full cash flow conversion analysis, see NLS Pharmaceutics AG cash conversion from operations.
Annual Financial Flexibility Index for NLS Pharmaceutics AG (2017–2024)
Year-by-year free cash flow to debt coverage for NLS Pharmaceutics AG. Explore NLSP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.16x | $-4.26 Million | $-4.27 Million | $826.76K | ▼ -468.8% |
| 2023 | -0.91x | $-9.68 Million | $-9.68 Million | $10.68 Million | ▲ +60.8% |
| 2022 | -2.31x | $-13.88 Million | $-13.88 Million | $6.00 Million | ▲ +18.8% |
| 2021 | -2.85x | $-14.90 Million | $-14.94 Million | $5.22 Million | ▼ -3887.3% |
| 2020 | -0.07x | $-729.38K | $-729.39K | $10.20 Million | ▼ -226.5% |
| 2019 | -0.02x | $-150.45K | $-190.01K | $6.87 Million | ▲ +92.7% |
| 2018 | -0.30x | $-2.69 Million | $-2.73 Million | $8.96 Million | ▲ +44.6% |
| 2017 | -0.54x | $-5.43 Million | $-5.43 Million | $10.01 Million | — |